Phage probes for malignant glial cells

Molecular Cancer Therapeutics

Volumn 2, Issue 11, 2003, Pages 1129-1137

  Samoylova, Tatiana I ^a   Petrenko, Valery A ^a   Morrison, Nancy E ^a   Globa, Ludmila P ^a   Baker, Henry J ^a   Cox, Nancy R ^a  

^a AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; PEPTIDE LIBRARY;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BACTERIOPHAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GLIA; GLIOMA; METABOLISM; PATHOLOGY; PROTEIN MOTIF; RAT; TUMOR CELL LINE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; BACTERIOPHAGES; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; LIGANDS; NEUROGLIA; PEPTIDE LIBRARY; RATS;

EID: 1342265100     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Lleonart, M. E., Martin-Duque, P., Sanchez-Prieto, R., Moreno, A., and Cajal, S. Tumor heterogeneity: morphological, molecular and clinical implications. Histol. Histopathol., 15: 881-898, 2000. (Pubitemid 30496566)
2. Chung, C. H., Bernard, P. S., and Perou, C. M. Molecular portraits and the family tree of cancer. Nat. Genet., 32 (Suppl.): 533-540, 2002. (Pubitemid 35435158)
3. Hanash, S. M., Bobek, M. P., Rickman, D. S., Williams, T., Rouillard, J. M., Kuick, R., and Puravs, E. Integrating cancer genomics and proteomics in the post-genome era. Proteomics, 2: 69-75, 2002. (Pubitemid 34273100)
4. Aina, O. H., Sroka, T. C., Chen, M. L., and Lam, K. S. Therapeutic cancer targeting peptides. Biopolymers, 66: 184-199, 2002. (Pubitemid 35285218)
5. Kuan, C. T., Wikstrand, C. J., and Bigner, D. D. EGF mutant receptor vIII as a molecular target in cancer therapy. Endocr. Relat. Cancer, 8: 83-96, 2001. (Pubitemid 32641351)
6. Smits, A. and Funa, K. Platelet-derived growth factor (PDGF) in primary brain tumours of neuroglial origin. Histol. Histopathol., 13: 511-520, 1998. (Pubitemid 28197714)
7. Kruse, C. A., Varella-Garcia, M., Kleinschmidt-DeMasters, B. K., Owens, G. C., Spector, E. B., Fakhrai, H., Savelieva, E., and Liang, B. C. Receptor expression, cytogenetic, and molecular analysis of six continuous human glioma cell lines. In Vitro Cell. Dev. Biol. Anim., 34: 455-462, 1998. (Pubitemid 29071769)
8. Joshi, B. H., Leland, P., Asher, A., Prayson, R. A., Varricchio, F., and Puri, R. K. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures. Cancer Res., 61: 8058-8061, 2001. (Pubitemid 33091589)
9. Bernard, J., Treton, D., Vermot-Desroches, C., Boden, C., Horellou, P., Angevin, E., Galanaud, P., Wijdenes, J., and Richard, Y. Expression of interleukin 13 receptor in glioma and renal cell carcinoma: IL13Rα2 as a decoy receptor for IL13. Lab. Invest., 81: 1223-1231, 2001. (Pubitemid 32911971)
10. Hall, W. A. Targeted toxin therapy for malignant astrocytoma. Neurosurgery, 46: 544-551, 2000.
11. Mori, T., Abe, T., Wakabayashi, Y., Hikawa, T., Matsuo, K., Yamada, Y., Kuwano, M., and Hori, S. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-α or basic fibroblast growth factor. J. Neuro-oncol., 46: 115-123, 2000. (Pubitemid 30352618)
12. Soroceanu, L., Gillespie, Y., Khazaeli, M. B., and Sontheimer, H. Use of chlorotoxin for targeting of primary brain tumors. Cancer Res., 58: 4871-4879, 1998. (Pubitemid 28503684)
13. Ransom, C. B., O'Neal, J. T., and Sontheimer, H. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J. Neurosci., 21: 7674-7683, 2001. (Pubitemid 32904966)
14. Yamamoto, M., Mohanam, S., Sawaya, R., Fuller, G. N., Seiki, M., Sato, H., Gokaslan, Z. L., Liotta, L. A., Nicolson, G. L., and Rao, J. S. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res., 56: 384-392, 1996. (Pubitemid 26026369)
15. Goldbrunner, R. H., Bernstein, J. J., and Tonn, J. C. Cell-extracellular matrix interaction in glioma invasion. Acta Neurochir. (Wien.), 141: 295-305, 1999. (Pubitemid 29137544)
16. Ranuncolo, S. M., Ladeda, V., Specterman, S., Varela, M., Lastiri, J., Morandi, A., Matos, E., Bal de Kier, Joffe E., Puricelli, L., and Pallotta, M. G. CD44 expression in human gliomas. J. Surg. Oncol., 79: 30-35, 2002.
17. Breyer, R., Hussein, S., Radu, D. L., Putz, K. M., Gunia, S., Hecker, H., Samii, M., Walter, G. F., and Stan, A. C. Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody. J. Neurosurg., 92: 140-149, 2000. (Pubitemid 30022098)
18. Petrenko, V. A., Smith, G. P., Gong, X., and Quinn, T. A library of organic landscapes on filamentous phage. Protein Eng., 9: 797-801, 1996. (Pubitemid 26308528)
19. Barbas C. F. I., Burton D. R., Scott, J. K., and Silverman, G. J. (eds). Phage Display: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2001.
20. Barry, M. A., Dower, W. J., and Johnston, S. A. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat. Med., 2: 299-305, 1996. (Pubitemid 26080650)
21. Ko, L., Koestner, A., and Wechsler, W. Morphological characterization of nitrosourea-induced glioma cell lines and clones. Acta Neuropathol. (Berl.), 51: 23-31, 1980. (Pubitemid 10080528)
22. Barth, R. F. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. J. Neurooncol., 36: 91-102, 1998. (Pubitemid 28230658)
23. Mammen, M., Choi, S. K., and Whitesides, G. M. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew. Chem., Int. Ed., 37: 2754-2794, 1998. (Pubitemid 29008561)
24. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell Dev. Biol., 12: 697-715, 1996. (Pubitemid 26422728)
25. Bafetti, L. M., Young, T. N., Itoh, Y., and Stack, M. S. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem., 273: 143-149, 1998. (Pubitemid 28042187)
26. Taga, T., Suzuki, A., Gonzalez-Gomez, I., Gilles, F. H., Stins, M., Shimada, H., Barsky, L., Weinberg, K. I., and Laug, W. E. αv-Integrin antagonist EMD 121974 induces apoptosis in brain tumor cells growing on vitronectin and tenascin. Int. J. Cancer, 98: 690-697, 2002. (Pubitemid 34228889)
27. Spear, M. A., Breakefield, X. O., Beltzer, J., Schuback, D., Weissleder, R., Pardo, F. S., and Ladner, R. Isolation, characterization, and recovery of small peptide phage display epitopes selected against viable malignant glioma cells. Cancer Gene Ther., 8: 506-511, 2001. (Pubitemid 32737837)